You are here: Industry Insights > GSK

News List

Changes of the Global HIV Drug Market in 10 Years 1℃
September 30, 2018
Gilead Sitting Atop, the Quadruple Regimen Genvoya Fast Growing into a Star of Today
GSK candidate vaccine helps prevent active pulmonary tuberculosis in HIV negative adults expressbpd
September 27, 2018
Publication of primary results in the New England Journal of Medicine shows positive impact of innovative vaccine technology in clinical trial conducted in tuberculosis endemic regions
GSK grabs new drug development head from Boehringer expressbpd
September 21, 2018
GlaxoSmithKline has hired Chris Corsico from German drugmaker Boehringer Ingelheim to fill the new role of senior vice-president development as the company reshapes its research strategy, a spokesman for the British group said recently.
US regulators reject GSK’s Nucala for COPD pharmatimes
September 13, 2018
GlaxoSmithKline’s bid to expand the use of its biologic Nucala in the US to include patients with coronary pulmonary obstructive disorder (COPD) has hit a significant setback.
Drugmaker GSK to eliminate 650 US jobs financialexpress
September 07, 2018
The savings from these cuts will help fund increases in research and development and commercial support of new products, Rhyne said
$3 million GSK verdict thrown out of court pharmafile
August 27, 2018
A $3 million verdict against British multinational GlaxoSmithKline has been thrown out after a US appeals court said tha
AstraZeneca shocked as inhaler fails to outclass GSK rival in COPD pharmafile
August 27, 2018
Researchers at AstraZeneca have been left scratching their heads as new Phase 3b results for its inhaler, Bevespi Aerosphere, posted disappointing results compared to a rival product......
Orchard raises $150m to advance gene therapies pharmatimes
August 15, 2018
UK-American biotech Orchard Therapeutics has raised $150 million to fuel development of its gene therapy pipeline.
Fresh from GSK deal, Orchard raises $150M for multifront late-phase gene therapy push fiercebiotech
August 14, 2018
Orchard Therapeutics has raised $150 million (€132 million) to advance three gene therapies toward approval. The series C round continues a transformative year for Orchard defined by the acquisition of GlaxoSmithKline’s portfolio of approved and experimen
GSK Ships Seasonal Influenza Vaccines for US Market americanpharmaceuticalreview
August 13, 2018
GSK today announced it will begin shipping its quadrivalent influenza vaccines to US healthcare providers and pharmacies for the 2018-19 flu season.....

Previous page 1 2 3 4 5 6 7 8 9 10 ... 40 41 Next page